Apnimed, Inc.
NASDAQ:APMDBiotechnology
+$0.71 today
- Market cap
- $726.46M
- Beta
- 0.00
Volume 0.30M
Average 1.15M
APMD Other Non-current Liabilities
Long-term obligations not reported separately, such as lease or pension liabilities.
Other Non-current Liabilities history
Currency unavailable · from the balance sheet
No Other Non-current Liabilities data reported for this period type.
Other Non-current Liabilities vs competitors
How APMD compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | €1.04M EUR | +9.9% | +187.0% | 1.1% | |
| Jun 2026 | $136K USD | +22.5% | — | 0.0% | |
APMDApnimed, Inc. | — | — | — | — | — |
| Peer median (excluding APMD) | — | +16.2% | +187.0% | 0.5% | |
Competitors are the stored peer set for APMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Apnimed, Inc.
NASDAQ:APMD
Intrinsic Alpha fair value
Locked
Current Price
$17.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.